Hidradenitis suppurativa - prevalence analyses of German statutory health insurance data
J Eur Acad Dermatol Venereol
.
2021 Jan;35(1):e32-e35.
doi: 10.1111/jdv.16783.
Epub 2020 Jul 20.
Authors
S Schneider-Burrus
1
,
G Lux
2
,
K van der Linde
2
,
S Barbus
3
,
J Huss-Marp
3
,
A Tsaousi
4
,
J Wasem
2
,
B Wolff
3
,
R Sabat
4
5
Affiliations
1
Department for Dermatosurgery, Havelklinik, Berlin, Germany.
2
Institute for Health Care Management and Research, University Duisburg-Essen, Duisburg, Germany.
3
AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany.
4
Psoriasis Research and Treatment Centre, Charité - Universitätsmedizin Berlin, Berlin, Germany.
5
Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
PMID:
32580237
DOI:
10.1111/jdv.16783
No abstract available
Publication types
Letter
MeSH terms
Germany / epidemiology
Hidradenitis Suppurativa* / epidemiology
Humans
Insurance, Health
National Health Programs
Prevalence
Grants and funding
AbbVie